Gene · 64109
Papers2,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer. | Microorganisms | 2024 | 39770638 | PubTator, text mining | PubMed |
| Thymic stromal lymphopoietin modulates T cell response and improves cardiac repair post-myocardial infarction. | Front Immunol | 2024 | 39703503 | PubTator, text mining | PubMed |
| Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia. | Ann Hematol | 2024 | 39592470 | PubTator, text mining | PubMed |
| Targeted Degradation of Receptor-Interacting Protein Kinase 1 to Modulate the Necroptosis Pathway. | ACS Pharmacol Transl Sci | 2024 | 39539258 | PubTator, text mining | PubMed |
| Elevated circulating group-2 innate lymphoid cells expressing activation markers and correlated tryptase AB1 levels in active ascariasis. | Front Immunol | 2024 | 39524451 | PubTator, text mining | PubMed |
| CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy. | J Immunother Cancer | 2024 | 39461880 | PubTator, text mining | PubMed |
| Expression of Epithelial Alarmin Receptor on Innate Lymphoid Cells Type 2 in Eosinophilic Chronic Obstructive Pulmonary Disease. | Adv Respir Med | 2024 | 39452061 | PubTator, text mining | PubMed |
Judicious use of precise fluorescence in situ hybridisation panels guided by population prevalence may assist pragmatic detection of clinically targetable Philadelphia chromosome-like acute lymphoblastic leukaemia fusions: a systematic review. | Pathology | 2024 | 39304495 | PubTator, text mining | PubMed |
| Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review. | Ann Hematol | 2024 | 39167182 | PubTator, text mining | PubMed |
| Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report. | BMC Pediatr | 2024 | 39127642 | PubTator, text mining | PubMed |
| Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia. | J Clin Oncol | 2024 | 39102629 | PubTator, text mining | PubMed |
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening. | Heliyon | 2024 | 39071567 | PubTator, text mining | PubMed |
| Increased AID results in mutations at the CRLF2 locus implicated in Latin American ALL health disparities. | Nat Commun | 2024 | 39068148 | PubTator, text mining | PubMed |
| CRLF2 and IKZF1 abnormalities in childhood hematological malignancies other than B-cell Acute Lymphoblastic Leukemia. | Leuk Lymphoma | 2024 | 39034479 | PubTator, text mining | PubMed |
| Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. | J Clin Oncol | 2024 | 39028925 | PubTator, text mining | PubMed |
| Atopic Dermatitis Complicated by Recurrent Eczema Herpeticum Is Characterized by Multiple, Concurrent Epidermal Inflammatory Endotypes. | JID Innov | 2024 | 39006317 | PubTator, text mining | PubMed |
| Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). | Eur J Med Chem | 2024 | 39004018 | PubTator, text mining | PubMed |
| The Role of the JAK-STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2024 | 38999955 | PubTator, text mining | PubMed |
| Ubiquitin recruiting chimera: more than just a PROTAC. | Biol Direct | 2024 | 38978100 | PubTator, text mining | PubMed |
| Intrinsic signaling pathways modulate targeted protein degradation. | Nat Commun | 2024 | 38956052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64109/papers?page=6